Neuraxis Stock Analysis

NRXS Stock   4.46  0.08  1.76%   
At this time, Neuraxis' Short and Long Term Debt is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 305.6 K in 2026, despite the fact that Net Debt is likely to grow to (2.8 M). Neuraxis' financial risk is the risk to Neuraxis stockholders that is caused by an increase in debt.
 
Debt Ratio  
First Reported
2010-12-31
Previous Quarter
0.11
Current Value
0.11
Quarterly Volatility
0.14648607
 
Credit Downgrade
 
Yuan Drop
 
Covid
Total Current Liabilities is likely to gain to about 3 M in 2026. Liabilities And Stockholders Equity is likely to gain to about 5.7 M in 2026
Neuraxis is fairly valued with Real Value of 4.5 and Target Price of 5.0. The main objective of Neuraxis stock analysis is to determine its intrinsic value, which is an estimate of what Neuraxis is worth, separate from its market price. There are two main types of Neuraxis' stock analysis: fundamental analysis and technical analysis.
The Neuraxis stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Neuraxis is usually not traded on Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday. Neuraxis Stock trading window is adjusted to America/New York timezone.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neuraxis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued.
For more information on how to buy Neuraxis Stock please use our How to Invest in Neuraxis guide.

Neuraxis Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.05. Neuraxis had not issued any dividends in recent years. To find out more about Neuraxis contact Brian Carrico at 812 689 0791 or learn more at https://neuraxis.com.

Neuraxis Quarterly Total Revenue

811,414

Neuraxis Investment Alerts

Neuraxis is way too risky over 90 days horizon
Neuraxis appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 2.69 M. Net Loss for the year was (8.24 M) with profit before overhead, payroll, taxes, and interest of 2.84 M.
Neuraxis generates negative cash flow from operations
Neuraxis has a frail financial position based on the latest SEC disclosures
About 19.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Portfolio Recap Can NeurAxis Inc stock weather global recession - Quarterly Investment Review Stepwise Trade Execution Plans - moha.gov.vn

Neuraxis Upcoming and Recent Events

6th of June 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Neuraxis Largest EPS Surprises

Earnings surprises can significantly impact Neuraxis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-08-12
2025-06-30-0.19-0.22-0.0315 
2025-05-12
2025-03-31-0.24-0.33-0.0937 
2024-02-28
2023-12-31-0.15-0.2547-0.104769 
View All Earnings Estimates

Neuraxis Environmental, Social, and Governance (ESG) Scores

Neuraxis' ESG score is a quantitative measure that evaluates Neuraxis' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Neuraxis' operations that may have significant financial implications and affect Neuraxis' stock price as well as guide investors towards more socially responsible investments.

Neuraxis Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.47 M.

Neuraxis Profitablity

The company has Profit Margin (PM) of (2.24) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.59) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.59.
Last ReportedProjected for Next Year
Return On Tangible Assets(2.03)(2.14)
Return On Capital Employed(3.54)(3.36)
Return On Assets(1.99)(2.09)
Return On Equity(3.59)(3.41)

Management Efficiency

Neuraxis has return on total asset (ROA) of (1.3692) % which means that it has lost $1.3692 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (30.7115) %, meaning that it created substantial loss on money invested by shareholders. Neuraxis' management efficiency ratios could be used to measure how well Neuraxis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -2.14 in 2026. Return On Capital Employed is likely to gain to -3.36 in 2026. At this time, Neuraxis' Total Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 338.5 K in 2026, whereas Non Current Assets Total are likely to drop slightly above 519 K in 2026.
Last ReportedProjected for Next Year
Book Value Per Share 0.34  0.36 
Tangible Book Value Per Share 0.33  0.34 
Enterprise Value Over EBITDA(1.48)(1.56)
Price Book Value Ratio 7.08  7.43 
Enterprise Value Multiple(1.48)(1.56)
Price Fair Value 7.08  7.43 
Enterprise Value15 M16.5 M
The management strategies employed by Neuraxis' are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Operating Margin
(2.59)
Profit Margin
(2.24)
Beta
3.164
Return On Assets
(1.37)
Return On Equity
(30.71)

Technical Drivers

As of the 2nd of January, Neuraxis secures the Downside Deviation of 5.15, mean deviation of 4.1, and Risk Adjusted Performance of 0.0948. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neuraxis, as well as the relationship between them. Please verify Neuraxis jensen alpha and semi variance to decide if Neuraxis is priced some-what accurately, providing market reflects its recent price of 4.46 per share. Given that Neuraxis has jensen alpha of 0.6565, we recommend you to check Neuraxis's last-minute market performance to make sure the company can sustain itself at a future point.

Neuraxis Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Neuraxis price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Neuraxis Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neuraxis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neuraxis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neuraxis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Neuraxis Outstanding Bonds

Neuraxis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neuraxis uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neuraxis bonds can be classified according to their maturity, which is the date when Neuraxis has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Neuraxis Predictive Daily Indicators

Neuraxis intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Neuraxis stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Neuraxis Forecast Models

Neuraxis' time-series forecasting models are one of many Neuraxis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Neuraxis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Neuraxis Bond Ratings

Neuraxis financial ratings play a critical role in determining how much Neuraxis have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Neuraxis' borrowing costs.
Piotroski F Score
3
FrailView
Beneish M Score
(2.50)
Unlikely ManipulatorView

Neuraxis Total Assets Over Time

Neuraxis Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Neuraxis uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Neuraxis Debt Ratio

    
  11.0   
It appears most of the Neuraxis' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Neuraxis' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Neuraxis, which in turn will lower the firm's financial flexibility.

Neuraxis Corporate Bonds Issued

Neuraxis Short Long Term Debt Total

Short Long Term Debt Total

450,396

At this time, Neuraxis' Short and Long Term Debt Total is comparatively stable compared to the past year.

About Neuraxis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Neuraxis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Neuraxis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Neuraxis. By using and applying Neuraxis Stock analysis, traders can create a robust methodology for identifying Neuraxis entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(3.53)(3.71)
Operating Profit Margin(3.06)(3.22)
Net Loss(3.53)(3.71)
Gross Profit Margin 0.78  0.67 

Current Neuraxis Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Neuraxis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Neuraxis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
5.0Strong Buy1Odds
Neuraxis current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Neuraxis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Neuraxis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Neuraxis, talking to its executives and customers, or listening to Neuraxis conference calls.
Neuraxis Analyst Advice Details

Neuraxis Stock Analysis Indicators

Neuraxis stock analysis indicators help investors evaluate how Neuraxis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Neuraxis shares will generate the highest return on investment. By understating and applying Neuraxis stock analysis, traders can identify Neuraxis position entry and exit signals to maximize returns.
Begin Period Cash Flow78.6 K
Total Stockholder Equity2.1 M
Net Borrowings4.7 M
Capital Lease Obligations319.3 K
Property Plant And Equipment Net374.6 K
Cash And Short Term Investments3.7 M
Net Invested Capital2.2 M
Cash3.7 M
50 Day M A2.8688
Net Interest Income-531.5 K
Total Current Liabilities2.4 M
Investments-27.8 K
Interest Expense300.7 K
Stock Based Compensation1.4 M
Common Stock Shares Outstanding6.9 M
Total Cashflows From Investing Activities-27.8 K
Free Cash Flow-6.1 M
Other Current Assets280.4 K
Accounts Payable596.9 K
Net Debt-3.2 M
Other Operating Expenses9.8 M
Non Current Assets Total491.4 K
Liabilities And Stockholders Equity4.8 M
Non Currrent Assets Other20.2 K

Additional Tools for Neuraxis Stock Analysis

When running Neuraxis' price analysis, check to measure Neuraxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuraxis is operating at the current time. Most of Neuraxis' value examination focuses on studying past and present price action to predict the probability of Neuraxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuraxis' price. Additionally, you may evaluate how the addition of Neuraxis to your portfolios can decrease your overall portfolio volatility.